(Q35758280)

English

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

scientific article published on 16 May 2005

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer (English)
William Kevin Kelly
Barbara MacGregore-Cortelli
Lawrence Schwartz
Victoria M Richon

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit